Treatment failure occurs when an ulcerative colitis medication isn’t helping symptoms. Most important, know that it’s not your fault. Learn what to do next.

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Next up video playing in 10 seconds Which Tests Check for Ulcerative Colitis Remission? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines the typ ...

Living with ulcerative colitis means navigating a complex and often unpredictable digestive condition that impacts daily life in profound ways. This inflammatory bowel disease affects approximately 1 ...

Ulcerative colitis (UC) is a lifelong condition. That means you may try a lot of different treatments — and know how frustrating it can be when they don’t help. The nature of UC is “flare and ...

WAS DIAGNOSED AFTER HAVING A BABY. AFTER HAVING A BABY, YOUR BODY CHANGES. BUT FOR ALISON MURDAUGH, SHE WENT TO THE DOCTOR AFTER REALIZING SOMETHING WASN’T QUITE RIGHT. SO THERE WAS SOME ABNORMAL ...

While complementary therapies won’t treat the underlying cause of ulcerative colitis (UC), they can help you manage your symptoms and improve your overall quality of life. Ulcerative colitis (UC) is ...

It’s becoming more common to treat ulcerative colitis with two biologic medications, or a biologic and a small molecule drug.

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Ulcerative colitis affects only the innermost lining of the bowel. Crohn’s disease, on the other hand, can involve all layers ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the large intestine, causing persistent inflammation in the colon and rectum. The condition typically begins in the rectum ...

The treatment for ulcerative colitis and Crohn’s disease combines two already available drugs that worked better in clinical trials than either drug alone, researchers report.